Background
DM is a chronic metabolic disorder resulting from either insulin insufficiency or insulin dysfunction [
1]. Global prevalence of DM is on the rise especially in developing nations. In India, the number of people suffering from DM has increased from 32 million in 2000 to 63 million in 2013 and is estimated to rise up to 101 million by 2030 [
2]. Diabetes is a polygenic disease with the involvement of oxidative stress and requires a multipronged therapeutic approach [
3]. There is a global resurgence of herbal drug usage with World health organization (WHO) promoting their amalgamation into the main stream medicine. Due to complex constitution, poly herbals appear to work in a dynamic way to produce better therapeutic activity by interacting with multiple receptor targets. In the Indian systems of medicine, traditional practitioners formulate and dispense their own formulations with combinations of rejuvenating herbs called rasayana drugs. Implicit presence of residual toxins [
4], personnel errors in plant collection, seasonal variations, ecotypic, genotypic and chemotypic changes are attributed to the failure of new herbal formulae from producing the intended therapeutic effects [
5]. Therefore, the development of standardized, safe and effective herbal formulations with better understanding of their molecular mechanisms offer alternatives in drug discovery for T2D [
6].
MD-1 is a poly herbal health supplement indicated in the management of diabetes. It is formulated as a hard gelatin capsule containing a dried and powdered mixture of six medicinal herbs reported for anti diabetic activity. This new herbal formula contains
Phyllanthus amarus (aerial parts) [
7],
Tinospora cordifolia (stems and leaves) [
8]
, Emblica officinalis (fruits) [
9] and
Eugenia jambolana (fruits) [
10],
Gymnema sylvestre (leaves) [
11] and
Cassia auriculata (flowers) [
12]. The composition of herbs is given Table
1. MD-1 is being used in clinical practice at a dose of 500 mg per day in pre diabetes and 1000 mg per day in T2D along with the regular prescription of medicine. It was observed that MD-1 supplementation reduced the risk of disease progression and regression from prediabetes to normal glucose regulation.
Table 1
Composition of MD-1
Phyllanthus amarus
| Aerial parts | 100 mg |
Tinospora cordifolia
| Stems and roots | 75 mg |
Emblica officinalis
| Fruits | 75 mg |
Eugenia jambolana
| Fruits | 75 mg |
Gymnema sylvestre
| Leaves | 100 mg |
Cassia auriculata
| Flowers | 75 mg |
The present work evaluated the quality of MD-1 as per Ayurvedic Pharmacoepia of India (API) procedures. Further the formulation was biochemically evaluated in vitro for antioxidant and anti diabetic activity. Effect of MD-1 on glucose uptake was studied in L6 myotubes and 3T3L1 mouse fibroblast cell lines. Effect of MD-1 on lipid metabolism was assessed in 3T3L1 cells. The mRNA expression of PPARγ and its target gene GLUT4 was investigated in 3T3L1 cell lines to understand the mechanism of action involved.
Methods
Materials
MD-1 capsules (3 different batches) were purchased from Isha Arogya, Chennai, Tamilnadu. The capsule contents were collected from twenty capsules of each batch and stored in a amber colour container at room temperature. Calibration standards for heavy metal analysis (Cd, Pb, As, Hg) were purchased from Merck, Germany. 2-Deoxy- D-[1-3H] glucose was purchased from PerkinElmer, USA. Insulin, dexamethasone (DEX), Iso Butyl Methyl Xanthine (IBMX) were purchased from Sigma Aldrich, USA. Pioglitazone (PGZ) was a kind gift from Dr. Reddys Laboratories, India. All other chemicals and solvents were of analytical grade obtained from SISCO Research Laboratories Pvt Ltd. India.
Physico chemical evaluation
The MD-1 herbal mixture was evaluated for organoleptic properties [
13], pH, ash values, extractive values, foreign matter and moisture content as per standard protocols given by API [
14].
Determination of toxic contaminants
The residual analysis was performed to estimate the toxic contaminants like heavy metals, pesticide residues, aflatoxins and microbial load.
Heavy metal analysis was performed according to the API guidelines [
15]. Sample digestion was carried out by acid digestion method using nitric acid to determine the heavy metal content. After digestion, the samples were analyzed in Atomic Absorption Spectrometer (PERKIN ELMER AAS- 200) for Lead (Pb), Arsenic (As), Cadmium (Cd) and Mercury (Hg). The mercury vapour atomization and hybrid vapour generation attachments were used for AAS analysis of Hg and As respectively. The standards of Pb, As, Cd and Hg (Merck, Germany) were used for the the development of calibration curves.
Pesticide analysis
The samples were prepared by QuEChERS method to determine the pesticide content [
16]. The sample was homogenized by blender and extracted with 1% acetic acid buffer. Internal standards were added to the extraction mixture and shaken vigorously for 1 min. After centrifugation at 1500 g for 1 min, the supernatant was collected and treated with magnesium sulphate for clean up. After 30 s, the supernatant was collected by centrifugation at 1500 g for 1 min and used for analysis. The quantitative estimation of organo chlorine, organo phosphorous and pyrethroids was carried out using GC/MS analysis in a DB-5 (30 m × 0.25 mm × 0.25 μm) capillary column (Agilent 7000 Triple Quad GC/MS, USA) [
17]. Recovery studies with purified compounds indicated that the overall recovery value was 85%.
Aflatoxin determination
The samples were extracted using methanol: water (17:3) mixture to estimate the aflatoxin content. The filtrate was treated with zinc acetate: aluminium chloride reagent to avoid the interfering pigments. Further, clean up was carried out as per the procedures given by API [
15]. Aflatoxins were estimated using Waters Alliance 2695 HPLC instrument using a Luna C18 column (Phenomenex) of dimensions 4.6 × 150 mm × 5 μ coupled with Waters 2475 fluorescence detector containing Cobra cell [
17]. The excitation wavelength and the emission wavelength for fluorescent detection were set at 362 nm and 455 nm, respectively. The calibration standards were procured from Sigma Aldrich.
Microbial load analysis
Microbial analysis was carried out as per API guidelines [
15]. The sample was suspended in 0.1%
w/
v of polysorbate 80 and kept on a mechanical shaker for few minutes. The dilution was 1:100 or 10
− 2 from, which 1 mL was transferred to 9 mL of sterilized distilled water to make a 1:1000 dilution and this procedure was repeated up to 10
− 6 dilution. Each 0.1 mL of serially diluted sample was inoculated to the sterile plates containing casein soya bean digest agar and plates were incubated at 37 °C for 24 h to evaluate the bacterial count. Further, the samples were incubated in Sabouraud dextrose agar plates at room temperature for 5 days to evaluate the fungal load. The bacterial and fungal colonies were counted using a colony counter. The presence of specific micro-organisms
Escherichia coli, Salmonella ebony, Pseudomonas aeruginosa and
Staphylococcus aureus was identified using biochemical tests such as indole test, triple sugar test, oxidase test and coagulase test, respectively.
The sample (5 g) was extracted thrice with 70% methanol (3Χ25 mL) by cold maceration for 24 h. The filtrate was concentrated in a rotary vacuum evaporator (Superfit, India) at 60 °C (yield 10.32 %W/W; 51.6 mg/capsule).
Phyto chemical analysis
HAEF was dissolved in ethanol: water (7:3) mixture to obtain 1%
w/
v solution and used for qualitative [
18] and quantitative estimation of phytochemicals. The total phenol content was estimated using Folin-ciocalteau method [
19] and calculated as gallic acid equivalents. The total flavonoid content was determined using AlCl
3 method [
20] and calculated as quercetin equivalents.
In vitro efficacy studies
Cell culture
L6 myocytes and 3T3L1 preadipocytes were procured from the National Centre for Cell Science, Pune and maintained in Dulbeccos Modified Eagle Medium (DMEM) containing high glucose with 10% fetal bovine serum (FBS) and supplemented with penicillin (5 units/mL) and streptomycin (5 μg/mL) in 5% CO2 incubator at 37 °C. HAEF stock solution (5 mg/mL) was prepared using 10% DMSO and dilutions were prepared in DMEM medium. Addition of HAEF did not affect the pH of culture media (7.35–7.45) as monitored by the color change with the phenol red indicator included in the medium as well as measurements made using pH meter (Mettler Toledo, India).
Cytotoxicity
The cytotoxicity of HAEF in both cell lines was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) colorimetric assay [
26]. Briefly, the cells were seeded in a 96-well plate at a density of 5× 10
3 cells/well in DMEM high glucose media with 10% FBS. After 24 h, the cells were treated with HAEF at different concentrations in serum free media for 24 h and 7 days in L6, 3T3L1 cells respectively. Post incubation, the MTT assay was carried out and the absorbance was measured at 570 nm in multi mode reader (Perkin Elmer, USA). HAEF was found to be safe up to the concentration of 250 μg/mL (Fig.
4a,
b).
Effect of HAEF on glucose uptake
Effect of HAEF on glucose uptake was studied in L6 myotubes and 3T3L1 adipocytes as per the reported method [
27] with slight modifications. Briefly, post confluence, L6 cells were transferred to DMEM media with 2% FBS for 4 days to induce myotube formation. After two days of confluence, the 3T3L1 pre adipocytes were switched to differentiation medium containing 0.25 μM DEX, 0.5 mM IBMX and 1 mg/L of insulin in DMEM medium with 10% FCS to induce differentiation (day 0). After 72 h of induction, the media was replaced with maintenance media containing 1 mg/mL insulin for 48 h (day 5). The media was subsequently replaced again with fresh culture media (DMEM with 10% FBS), after 2 days. After differentiation, the cells were serum starved for 5 h and incubated with HAEF for 24 h. Cells were stimulated with 100 nM insulin or left untreated for 30 min. After incubation with 0.5 μCi/mL 2-DG for 15 min, cells were washed with phosphate buffered saline (PBS) and lysed with 0.1% sodium dodecyl sulphate (SDS). The cell lysates were transferred to scintillation cocktail to measure radioactivity using liquid scintillation counter (Perkin Elmer, USA). Results were expressed as percentage glucose uptake relative to their respective controls. PGZ was used as a standard drug.
Effect of HAEF on triglyceride accumulation [28]
3T3L1 pre adipocytes were cultured in 48 well plate. After two days of confluence, differentiation was induced as mentioned above. Pre adipocytes were maintained with fresh growth media every other day throughout the experiment. The cells were treated with HAEF through day 0 to day 7 to study the effect of HAEF on differentiation. Oil O red staining was performed to visualize the triglyceride accumulation and microscopic images were captured using Nikon digital camera. The stain was further collected into isopropanol and quantified using multi plate reader (Perkin Elmer, USA) at 492 nm.
mRNA expression of PPARγ and glut 4 in 3T3L1 cell line
The 3T3L1 cells were seeded in a six well plate at a density of 1× 106 cells and cultured in differentiation medium with HAEF to study the effect of HAEF on the mRNA expression of adipocyte specific genes. Total RNA was isolated using TRIZOL reagent and quantified using biophotometer (Eppendorf, Germany). About 1 μg of total RNA was converted into cDNA using Thermoscientific verso cDNA synthesis kit, according to the manufacturer’s instructions. Reverse transcriptase polymerase chain reaction (RT –PCR) was performed using the Amplicon master mix as per manufacturer’s protocol. The primer sequences used for PCR analysis were as follows:PPARγ:5’-ACCTGAAGCTCCAAGAATACCA-3′(forward) and 5’-TAAGCTTCAATCGGATGGTTCT-3′(reverse),GLUT4:5’ TGGACCTGTAACTTCATTGTCG-3′(forward) and 5’-TCTGTACTGGGTTTCACCTCCT-3′(reverse), GAPDH:5’-ACCACAGTCCATGCCATC-3′(forward) and 5’-TCCACCACCCTGTTGCTG-3′(reverse). The reaction mixture was subjected to denaturation, annealing and extension at 95 °C for 30 s, 57 °C for 30 s, 72 °C for 1 min for 35 cycles in Master cycler gradient (Eppendorf, Germany). PCR products were analysed by electrophoresis in 1% agarose gel at 80 V and the fragments were visualized by safe dye staining. Photo documentation was performed using Quantity One 1-D Analysis Software. The gene expression was shown as ratio of densitometry value of target mRNA to that of GAPDH.
Statistical analysis
Statistical analysis was performed using Graph pad prism software version 6. (Graph pad software,USA). Unpaired t test was used to compare the difference between the test and standard. One way ANOVA followed by post hoc Dunnet’s test was used to compare the means between different groups. Two-way repeated measures ANOVA with Bonferroni correction was performed to compare all time course data within the groups. P < 0.05 was considered to be statistically significant.
Discussion
WHO recommends the standardization of HMPs, pending which many herbal formulations remain as herbal supplements which are otherwise part of first line approach in clinical practice [
31]. MD-1 is one such formulation that has been in clinical practice for the management of pre diabetes and T2D. In this study MD-1 has been evaluated for its quality according to API standard procedures. Biochemical and in vitro efficacy studies have been carried out to ascertain the possible mechanisms underlying the anti-diabetic action of MD-1.
The physicochemical parameters established for MD-1 may serve as reference standards in regular quality checks. As per WHO, presence of heavy metals, aflatoxins, pesticide residues and pathogenic microorganisms in herbal medicinal products (HMPs) make them non-compliant with the quality requirements of the regulatory authorities [
32]. In this context, the absence of toxic residues in MD-1 ensures the quality of starting material/ medicinal herbs which are compliant with WHO guidelines on Good Agricultural and collection practices (GACP).
In diabetes, elevated levels of glucose enhance the gene and protein expression of eNOS and iNOS thereby increased production of NO which leads to oxidative stress [
33]. Likewise many of the biochemical pathways associated with hyperglycemia will increase the production of free radicals [
34]. The strong antioxidant activity demonstrated by MD-1 would possibly bring about the reduction of oxidative stress in diabetes and prediabetes. The presence of large amounts of poly phenols in HAEF was amply supportive of the observed antioxidant activity [
35].
AGEs are proteins or lipids that become glycated as a result of exposure to sugars. Hyper glycaemia, auto-oxidation of glucose, glycation of proteins and anti-oxidant enzymes reportedly contribute to the etiology of oxidative stress in diabetes [
36]. The anti glycation activity demonstrated by HAEF indicates that MD-1 supplementation may control the development of associated micro vascular complications in diabetes patients. Literature reports on the glycation protective effect of antioxidants such as vitamin C, poly phenols and flavonoids [
37] endorsed the observed activity of the polyphenol rich HAEF in anti oxidant activity, thereby also substantiating its effect on AGEs formation.
Inhibition of carbohydrate enzymes in the intestinal lumen is one of the important therapeutic approaches in DM. Inhibition of these enzymes helps to reduce the post-prandial hyperglycemia in diabetes patients [
38]. The inhibition of α-glucosidase and α-amylase enzymes by HAEF is expounded by synergistic action of flavonoids, oleanane and ursane triterpenes which are reportedly present in the constituent herbs of the formulation.
Skeletal muscle and adipose tissue are the primary target site for insulin and play a crucial role in post prandial glucose regulation [
39]. Defects in signal transduction pathways and decreased GLUT4 translocation lead to the development of insulin resistance [
40]. The enhanced glucose uptake by HAEF is suggesting the beneficial effect of MD-1 supplementation in insulin resistance. Presence of phytochemicals like gallic acid [
41], ellagic acid [
42], berberine [
43] and quercetin [
44] with reported activation of AMPK pathway substantiated the observed glucose uptake by MD-1 in the absence of insulin. Reported amelioration of insulin resistance by the constituent herbs [
45,
46] lends support to the HAEF mediated 2-DG uptake in the presence of insulin.
Adipogenesis, the cellular differentiation of preadipocytes to adipocytes is described as a cascade of gene expressions regulated by a small set of transcription factors. PPARγ is a member of nuclear receptor super family that regulates the expression of many proteins involved in glucose homeostasis and plays a central role in adipocyte differentiation [
47]. PGZ is a synthetic TZD and a PPARγ agonist used in the treatment of DM to improve insulin sensitivity in the target tissues. Being potent adipogenesis inducers in vitro [
48], the TZDs reduced blood sugar in vivo despite the fact that their administration was often accompanied by the unpleasant side effect of weight gain and fluid retention [
49].
Several medicinal plant derived natural products have been identified as PPARγ modulators and have shown improvement in metabolic parameters in diabetic animal models with reduced drug associated toxicities compared to TZD agonists [
50]. Compared to the latter, these natural PPARγ ligands were reported to have different binding modes, thus accounting for the lack of delineation of their metabolic effects to PPARγ activation. Search for such PPARγ agonists that selectively modulate the receptor activity maintaining glucose homeostasis without the adverse effects associated with TZD is a promising approach in diabetes research [
51]. In this context, the observed anti adipogenic and insulin sensitizing effect of HAEF could be possibly attributable to mechanisms beyond PPARγ activation. Although HAEF displayed the enhancement of PPARγ and GLUT4 expression, it strongly inhibited the triglyceride accumulation and showed glucose uptake similar to PGZ. A weak PPARγ agonistic activity by HAEF was thus hypothesized, given the fact that majority of identified natural compounds acted as weak agonists with activation pattern distinct from full TZD agonists and more similar to endogenous ligands, such as fatty acids and prostanoids, having weaker activation potential.
The phyto chemical complexity of herbal drugs and evaluation of toxicity of bio-actives over parental extracts are the essential requirements for the development of standardized herbals rather than the less rewarding lead molecule isolation approach. Multi target mode of action, high safety and tolerability of phytotherapeutics offer valuable preventive and therapeutic options in holistic diabetes management. This work has laid the blue print for the quality control that is expected to pave way for use of this formulation as a dietary supplement in DM. The effects of MD-1 on glucose uptake, similar to PGZ, as observed on L6 and 3T3L1 cell lines pointed towards its favorable enhancement of insulin sensitivity. The mechanistic insights of PPARγ modulation by HAEF were suggestive of partial agonistic activity of the poly herbal formulation, possibly due to the presence of combinatorial ligands working in a dynamic way to selectively modulate PPARγ activity.